CUE
CUE clinical trials: Cue Biopharma, Inc.
Every trial on ClinicalTrials.gov where Cue Biopharma, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 5
- Trials linked
- 2
- As lead sponsor
- 3
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
CUE on the catalyst calendar · CUE registry changes
- Primary completion Mar 12, 2025ActualPhase 1NCT05360680A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic CancersCue Biopharma · Colorectal CancerCompletedCUELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 4, 2026ActualPhase 1NCT03978689A Phase 1 Study in Patients With HPV16+ Recurrent/ Metastatic Head and Neck Squamous Cell CarcinomaCue Biopharma · Head and Neck CancerCompletedCUELeadMRKCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 6, 2027Sponsor estimatePhase 2NCT04852328Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally...Washington University School of Medicine · Oropharyngeal Squamous Cell CarcinomaActive, not recruitingCUECollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 31, 2027Sponsor estimatePhase 1NCT06917885CUE-102 in Recurrent GlioblastomaDavid Reardon, MD · Recurrent GlioblastomaActive, not recruitingCUECollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2031Sponsor estimatePhase 2NCT07172256CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCsYale University · Head and Neck Squamous Cell CarcinomaRecruitingCUECollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 5 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner